drug protocol number

RC16/150

drug sponsor

KAIMRC

drug study

• DOXORUBICIN HYDROCHLORIDE• CYCLOPHOSPHAMIDE• VINBLASTINE SULPHATE • DACARBAZINE• BRENTUXIMAB VEDOTIN

drug trial site

King Abdulaziz Medical City NG (Riyadh)

drug status

Ongoing

drug phase